| 词条 | John F. Milligan |
| 释义 |
EducationMilligan received his bachelor's degree from Ohio Wesleyan University and doctorate from the University of Illinois-Urbana-Champaign.[1] He also was a postdoctoral fellow for the American Cancer Society at the University of California at San Francisco.[1] Milligan studied for two years at the University of Colorado Boulder BioFrontiers Institute under Olke C. Uhlenbeck while earning his degree in doctoral studies.[4] CareerUpon joining Gilead in 1990, Milligan has served multiple roles at the biotechnology company. After starting out as a research scientist, he has taken on leadership positions within the company which included Director of Project Management for the drug collaboration of Tamiflu with Hoffman-La Roche in 1996.[1] In March 2000, he became Vice President of Corporate Development and was responsible for coordinating licensing agreements between corporate partners as well as mergers and acquisitions to expand Gilead and develop its drug pipeline.[1] Additionally, he has been the Director of Pharmasset since January 2012 and Director of Pacific Biosciences since July 2013.[1] AchievementsIn 2006 and 2007, Institutional Investor magazine named Milligan top CFO in the biotechnology industry.[1] Also in 2006, he was distinguished as "Bay Area Chief Financial Officer of the Year" which is awarded to leaders of companies whose annual revenues exceed $500 million.[1] Most recently, in 2016, he was named to the Forbes Global Game Changers List which represents exceptional leaders and innovators in various industries.[5] References1. ^1 2 3 4 5 6 7 8 {{Cite web|url=https://www.bloomberg.com/research/stocks/private/person.asp?personId=2010644&privcapId=29002|title=Executive Profile|last=|first=|date=|website=Bloomberg.com|archive-url=|archive-date=|dead-url=|access-date=2017-02-18}} {{DEFAULTSORT:Milligan, John F.}}2. ^{{Cite news|url=https://www.bloomberg.com/news/articles/2016-05-06/gilead-new-ceo-says-it-s-time-to-go-out-and-do-important-deals|title=Gilead Chief Has $21 Billion in Cash and an Itch to Do a Deal|date=2016-05-06|newspaper=Bloomberg.com|access-date=2017-02-18}} 3. ^{{Cite web|url=http://www.businesswire.com/news/home/20160129005255/en/Gilead%E2%80%99s-John-C.-Martin-PhD-Assume-Role|title=Gilead’s John C. Martin, PhD to Assume Role of Executive Chairman of the Board; John F. Milligan, PhD to Be Appointed Chief Executive Officer and Director {{!}} Business Wire|website=www.businesswire.com|language=en|access-date=2017-02-18}} 4. ^{{Cite news|url=https://www.denverite.com/gilead-ceo-gives-1-million-endowment-cu-boulder-12160/|title=Gilead CEO gives $1 million endowment to CU Boulder - Denverite|date=2016-08-02|newspaper=Denverite|access-date=2017-02-18|language=en-US}} 5. ^{{Cite web|url=https://www.forbes.com/global-game-changers/#6063b2f491d3|title=Global Game Changers 2016|website=Forbes|access-date=2017-02-18}} 3 : American business executives|Year of birth missing (living people)|Living people |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。